What is NephroPlus?
NephroPlus is a prominent healthcare company in India, recognized for operating the nation's largest network of dialysis centers. The company's core mission revolves around delivering superior quality dialysis services while actively working to demystify and reduce the stress associated with the treatment for patients. By focusing on patient-centric care and operational excellence, NephroPlus has established itself as a leader in the healthcare sector, particularly in providing essential services to individuals with kidney-related ailments. Their commitment extends to improving the overall patient experience and accessibility of dialysis care.
How much funding has NephroPlus raised?
NephroPlus has raised a total of $155.1M across 5 funding rounds:
Series A
$4.3M
Series B
$10M
Series C
$15M
Series E
$24M
Series F
$101.8M
Series A (2011): $4.3M with participation from Bessemer Venture Partners
Series B (2014): $10M led by International Finance Corporation and Bessemer Venture Partners
Series C (2016): $15M supported by International Finance Corp and SeaLink Capital Partners
Series E (2021): $24M featuring IIFL Asset Management, Bessemer Venture Partners, and Investcorp
Series F (2024): $101.8M backed by Quadria Capital Investment Management
Key Investors in NephroPlus
Quadria Capital Investment Management
Quadria Capital is a leading private equity firm based in India and Singapore, focused on transforming healthcare in Asia through strategic investments in scalable healthcare companies. The firm emphasizes partnerships with organizations that have strong management teams and clear market differentiation, aiming to unlock value through deep domain expertise and operational experience.
International Finance Corp
International Finance Corporation operates as a multilateral financial institution dedicated to mobilizing capital and expertise for sustainable development across emerging markets. The organization provides comprehensive financial solutions that combine investment capital, strategic advisory services, and sophisticated asset management capabilities to support private sector growth and infrastructure development in developing economies.
SeaLink Capital Partners
SeaLink Capital Partners (SCP) is an investment firm focused on partnering with entrepreneurs and exceptional companies that exhibit strong growth potential and competitive differentiation. They are committed to providing high-quality, affordable, and accessible healthcare solutions, particularly in the dental sector, and seek long-term investors who share this vision.
What's next for NephroPlus?
With the recent major strategic investment and a substantial total funding amount of $155.1M, NephroPlus is poised for accelerated growth and expansion. The company is likely to leverage this capital to further enhance its technological infrastructure, broaden its geographical footprint within India, and potentially explore new service lines or partnerships. The enterprise-level funding suggests a focus on scaling operations, optimizing patient care pathways, and solidifying its market leadership. This strategic backing will enable NephroPlus to continue its mission of making dialysis care more accessible, affordable, and less stressful for a larger patient population.
See full NephroPlus company page
